Zoommed Inc (ZMMDF) 0.0130 $ZMMDF
As a Result of its Recent Sale of Assets, ZoomMed Announces a Delay in the Filing of its Annual Financial Statements
Marketwire - Fri Sep 26, 11:14AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed announces it should be unable to release on time its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014 (collectively, the "Annual Financial Statements 2014"
.
IIROC Trade Resumption - ZoomMed inc.
Newsfile Corp - Wed Sep 03, 9:01AM CDT
Trading resumes in:
ZoomMed Sells Interest in its ZRx Prescriber to TELUS Health for the Canadian Market for Up to $6,800,000
Marketwire - Wed Sep 03, 8:54AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed has sold an interest in the technology underlying its ZRx Prescriber Technology and certain related Canadian operations to TELUS Health for up to $6,800,000 which will allow ZoomMed's team to continue its worldwide distribution of its unique prescriber, with ongoing priority focus on the U.S. market. TELUS Health is Canada's largest Electronic Medical Records (EMR) provider and a leader in the Canadian claims and benefits management sector.
IIROC Trade Halt - ZoomMed inc.
Newsfile Corp - Wed Sep 03, 7:38AM CDT
The following issues have been halted by IIROC:
ZoomMed Signs an Agreement with Desjardins Insurance, the First Insurer in Canada to Work with an Electronic Prescriber
Marketwire - Tue Feb 18, 7:48AM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Company" or "ZoomMed" is pleased to announce that it has signed an agreement with Desjardins Insurance for the development and operation of a project focusing for a web-based solution to integrate selected insurance plan information into the ZRx Prescriber to provide physician users with information while they are entering prescriptions on their PC, tablet or smartphone.
ZoomMed Announces the Closing of a New Financing and the Repayment of its $1,5M Convertible Debenture
Marketwire - Thu Jan 16, 4:32PM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Corporation" announces the closing of a non-revolving loan, for a principal amount not exceeding US$2,000,000 (the "Loan" , of which US$1,664,318.92 has already been advanced, and the repayment of the CA$1,500,000 current convertible debenture.
ZoomMed Signs a US$3.5M Exclusive License Agreement for the Distribution and Licensing of the ZRx Prescriber in the U.S Market
Marketwire - Thu Apr 25, 8:47AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD), is very pleased to announce the signature of an Exclusive License Agreement regarding the rights to distribute, license and sub-license the ZRx Prescriber in the United States for a consideration of more than US$ 3.5M, with EvEMR Inc., a Washington D.C. based company.
ZoomMed: ZRx Prescriber Soon Available for Download on the "App Store"
Marketwire - Thu Feb 07, 9:00AM CST
ZoomMed inc. (TSX VENTURE: ZMD), is proud to announce the ZRx Prescriber will soon be available for download on the "App Store" by all potential users throughout North America.
As a Result of its Recent Sale of Assets, ZoomMed Announces a Delay in the Filing of its Annual Financial Statements
Marketwire - Fri Sep 26, 11:14AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed announces it should be unable to release on time its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014 (collectively, the "Annual Financial Statements 2014"
. IIROC Trade Resumption - ZoomMed inc.
Newsfile Corp - Wed Sep 03, 9:01AM CDT
Trading resumes in:
ZoomMed Sells Interest in its ZRx Prescriber to TELUS Health for the Canadian Market for Up to $6,800,000
Marketwire - Wed Sep 03, 8:54AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed has sold an interest in the technology underlying its ZRx Prescriber Technology and certain related Canadian operations to TELUS Health for up to $6,800,000 which will allow ZoomMed's team to continue its worldwide distribution of its unique prescriber, with ongoing priority focus on the U.S. market. TELUS Health is Canada's largest Electronic Medical Records (EMR) provider and a leader in the Canadian claims and benefits management sector.
IIROC Trade Halt - ZoomMed inc.
Newsfile Corp - Wed Sep 03, 7:38AM CDT
The following issues have been halted by IIROC:
ZoomMed Signs an Agreement with Desjardins Insurance, the First Insurer in Canada to Work with an Electronic Prescriber
Marketwire - Tue Feb 18, 7:48AM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Company" or "ZoomMed"
is pleased to announce that it has signed an agreement with Desjardins Insurance for the development and operation of a project focusing for a web-based solution to integrate selected insurance plan information into the ZRx Prescriber to provide physician users with information while they are entering prescriptions on their PC, tablet or smartphone. ZoomMed Announces the Closing of a New Financing and the Repayment of its $1,5M Convertible Debenture
Marketwire - Thu Jan 16, 4:32PM CST
ZoomMed Inc. (TSX VENTURE: ZMD) (the "Corporation"
announces the closing of a non-revolving loan, for a principal amount not exceeding US$2,000,000 (the "Loan" , of which US$1,664,318.92 has already been advanced, and the repayment of the CA$1,500,000 current convertible debenture. ZoomMed Signs a US$3.5M Exclusive License Agreement for the Distribution and Licensing of the ZRx Prescriber in the U.S Market
Marketwire - Thu Apr 25, 8:47AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD), is very pleased to announce the signature of an Exclusive License Agreement regarding the rights to distribute, license and sub-license the ZRx Prescriber in the United States for a consideration of more than US$ 3.5M, with EvEMR Inc., a Washington D.C. based company.
ZoomMed: ZRx Prescriber Soon Available for Download on the "App Store"
Marketwire - Thu Feb 07, 9:00AM CST
ZoomMed inc. (TSX VENTURE: ZMD), is proud to announce the ZRx Prescriber will soon be available for download on the "App Store" by all potential users throughout North America.
